BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27258205)

  • 1. Altered microrheological parameters in Raynaud's phenomenon.
    Papp J; Sandor B; Toth A; Biro K; Rabai M; Botor D; Kovacs D; Csernus Z; Toth K; Kesmarky G
    Clin Hemorheol Microcirc; 2017; 65(1):23-29. PubMed ID: 27258205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemorheological profile in primary and secondary Raynaud's phenomenon. Influence of microangiopathy.
    Vayá A; Alis R; Romagnoli M; Todolí J; Calvo J; Ricart JM
    Clin Hemorheol Microcirc; 2014; 56(3):259-64. PubMed ID: 23609604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Raynaud's phenomenon and blood viscosity].
    Lacombe C; Mouthon JM; Bucherer C; Lelievre JC; Bletry O; Godeau P
    J Mal Vasc; 1992; 17 Suppl B():132-5. PubMed ID: 1602250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheological properties of blood in Raynaud's phenomenon.
    Wichers G; Smit AJ; van der Meer J; Wouda AA; Halie MR
    Vasa Suppl; 1992; 34():29-33. PubMed ID: 1529415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Erythrocyte filterability in Raynaud's disease].
    Sciannameo F; Francucci M; Cao PG; Marianeschi P; Valentini M; Tockner M; Sassano L; Grasselli A
    Ric Clin Lab; 1983; 13 Suppl 3():475-80. PubMed ID: 6673030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of low titers of cryoglobulins and cold-agglutinins in patients with isolated Raynaud phenomenon.
    Kröger K; Billen T; Neuhaus G; Santosa F; Buss C; Kreuzfelder E; Henneberg-Quester KB
    Clin Hemorheol Microcirc; 2001; 24(3):167-74. PubMed ID: 11455056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood rheology in Raynaud's disease].
    Larcan A; Schmidt C; Stoltz JF; Voisin P
    J Mal Vasc; 1984; 9(1):1-6. PubMed ID: 6707529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood viscosity and local response to cold in primary Raynaud's phenomenon.
    Jahnsen T; Nielsen SL; Skovborg F
    Lancet; 1977 Nov; 2(8046):1001-2. PubMed ID: 72898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemorheological factors in Raynaud's phenomenon.
    Dintenfass L
    Angiology; 1977 Jul; 28(7):472-81. PubMed ID: 900567
    [No Abstract]   [Full Text] [Related]  

  • 10. Nomenclature of Raynaud's phenomenon: a capillary microscopic and hemorheologic study.
    Jacobs MJ; Breslau PJ; Slaaf DW; Reneman RS; Lemmens JA
    Surgery; 1987 Feb; 101(2):136-45. PubMed ID: 3810484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
    Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
    Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between capillaroscopy, haemorheological variables and plasma proteins in patients bearing Raynaud's phenomenon.
    Spengler MI; Svetaz MJ; Leroux MB; Leiva ML; Bottai HM
    Clin Hemorheol Microcirc; 2004; 30(1):17-24. PubMed ID: 14967879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemorrheology and neurovascular syndromes of the extremities].
    Sergio G; Artale F; Francisci A; Giunti P; Perego MA
    Ric Clin Lab; 1983; 13 Suppl 3():481-5. PubMed ID: 6673031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal blood viscosity in Raynaud's phenomenon.
    Goyle KB; Dormandy JA
    Lancet; 1976 Jun; 1(7973):1317-8. PubMed ID: 58309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorheological alterations in carotid artery stenosis.
    Totsimon K; Nagy A; Sandor B; Biro K; Csatho A; Szapary L; Toth K; Marton Z; Kenyeres P
    Clin Hemorheol Microcirc; 2016 Nov; 64(1):55-63. PubMed ID: 26890237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis and treatment of Raynaud's phenomenon.
    Porter JM; Snider RL; Bardana EJ; Rösch J; Eidemiller LR
    Surgery; 1975 Jan; 77(1):11-23. PubMed ID: 1078555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the Raynaud's phenomenon with piracetam.
    Moriau M; Lavenne-Pardonge E; Crasborn L; von Frenckell R; Col-Debeys C
    Arzneimittelforschung; 1993 May; 43(5):526-35. PubMed ID: 8328997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood viscosity, Raynaud's phenomenon and the effect of fibrinolytic enhancement.
    Ayres ML; Jarrett PE; Browse NL
    Br J Surg; 1981 Jan; 68(1):51-4. PubMed ID: 7459607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute carbon monoxide poisoning alters hemorheological parameters in human.
    Ozturk B; Arihan O; Coskun F; Dikmenoglu-Falkmarken NH
    Clin Hemorheol Microcirc; 2016; 61(4):591-7. PubMed ID: 25536918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemorheology in patients with Raynaud's phenomenon--diagnosis and therapy with plasmapheresis].
    Sakriss U; Toussaint C; Turowski A; Schmidt H; Nieter B
    Vasa Suppl; 1991; 32():347-9. PubMed ID: 1771530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.